Neutralizing antibody responses and cellular responses against severe acute respiratory syndrome coronavirus 2 omicron subvariant BA.5 after an mRNA severe acute respiratory syndrome coronavirus 2 vaccine dose in kidney transplant recipients
K. Kawashiro, R. Suzuki, T. Nogimori, N. Iwahara, T. Hirose, K. Okada, T. Yamamoto, T. Fukuhara, K. Hotta, N. Shinohara
This study evaluates antibody and cellular immune responses in kidney transplant recipients after three mRNA vaccine doses, finding lower neutralizing titers and T cell responses compared to healthy controls.
bioRxiv · Aug 2, 2023 · PreprintImmunology